Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


The Other Diabetes: An Interventional Market Emerges

This article was originally published in Start Up

Executive Summary

The American Society for Bariatric Surgery recently changed its name to the American Society for Bariatric and Metabolic Surgery, in recognition of the link between obesity and Type 2 diabetes. Published data has long shown that in many cases, when morbidly obese patients with Type 2 diabetes lose weight--through gastric bypass surgery or other means--their glucose levels return to normal. That's old news. But something new is happening: bariatric surgeons and companies with implantable devices originally intended for weight loss are publishing data that shows a reversal in Type 2 diabetes, sometimes independently of a reduction in weight, by some other mechanisms as yet unproven. In September, the "First World Congress On Interventional Therapies for Type 2 Diabetes" convened the clinical community and industry to discuss new treatment strategies.

Related Content


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts